4185.0: Tuesday, November 14, 2000: 2:30 PM-4:00 PM | ||||
| ||||
| The scientific explosion in the area of endocrine disruptors creates new implications and new challenges for public health advocates. There is now solid evidence linking chemicals commonly found in the environment with serious adverse health effects in laboratory animals and wildlife. Mechanisms of action involve estrogen, androgen, or thyroid disruption, and other hormonal effects. The implications for human health are enormous and require the attention of the public health community. In this session, we will present the latest data on endocrine disruptors, discuss the current regulatory approach to endocrine disrupting chemicals, and outline a public health response. Examples highlighting specific chemicals that are known or suspected endocrine disruptors will form the foundation of discussions about the limitations of risk assessment, the use of the Precautionary Principle, the need for improved public health surveillance, and the communication of environmental health issues to the public | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Gina M. Solomon | ||||
| Frontiers in environmental health: Endocrine disruption John Peterson Myers, PhD, Gina M. Solomon, MD, MPH | ||||
| Human exposure monitoring: Contaminant levels in the population David Wallinga, MD, MPA, Gina M. Solomon, MD, MPH | ||||
| Endocrine disruptors and current science policy developments Gina M. Solomon, MD, MPH | ||||
| Decision-making and the precautionary principle Ted Schettler, MD, MPH, Gina M. Solomon, MD, MPH | ||||
| Sponsor: | Environment | |||
| Cosponsors: | Epidemiology; Occupational Health and Safety; Socialist Caucus | |||